Application | Comment | Organism |
---|---|---|
medicine | overexpression of the enzyme correlates with a poor overall survival of ovarian cancer patients. CPT1A is a prognostic biomarker and rational target for therapeutic intervention of cancer | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
palmitoyl-CoA + L-carnitine | Homo sapiens | - |
CoA + L-palmitoylcarnitine | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P50416 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
CAOV-3 cell | - |
Homo sapiens | - |
ovarian cancer cell | - |
Homo sapiens | - |
ovarian serous carcinoma cell | - |
Homo sapiens | - |
OVCA-432 cell | - |
Homo sapiens | - |
OVCAR-3 cell | - |
Homo sapiens | - |
SKOV-3 cell | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
palmitoyl-CoA + L-carnitine | - |
Homo sapiens | CoA + L-palmitoylcarnitine | - |
? |
Synonyms | Comment | Organism |
---|---|---|
carnitine palmitoyl transferase-1A | - |
Homo sapiens |
CPT1A | - |
Homo sapiens |
General Information | Comment | Organism |
---|---|---|
malfunction | enzyme inactivation inhibits cell growth and ATP production and decreases tumorigenicity of ovarian cancer cells in severe combined immunodeficiency mice | Homo sapiens |
physiological function | ovarian cancer cells depend on or are addicted to enzyme-mediated fatty acid beta-oxidation for cell cycle progression | Homo sapiens |